What we're reading, September 15, 2016: A United Nations panel challenges the market-based approach to drug research and development; an FDA panel recommends removing a serious health warning from Chantix's label; and older patients may want to wait to get their flu shot.
The United Nations has released a report that challenges the market-based approach to drug research and development. According to Reuters, a panel set up last year recommends de-linking R&D costs and drug prices in some areas, such as tropical diseases and new antibiotics to fight “superbugs.” The report suggests a process for governments to negotiate agreements and attacks tactics by Western governments that are used to stop poorer countries from overriding drug patents under World Trade organization rules.
An FDA panel has recommended removing a serious warning about neuropsychiatric side effects from Chantix’s product labeling. The decision is a win for Pfizer, which will be able to widen the market for the smoking cessation pill, reported STAT. The drug maker has been trying to get the warning removed for 2 years. The panel made its decision based on a study that found Chantix does not appear to increase the risk of suicidal behavior, even though an FDA medical team voiced its doubts regarding the study.
While pharmacy chains are already calling for patients to get their flu shots, people may want to wait. While getting the flu shot early is better than not getting it at all, it’s unclear how long the vaccine’s immunity lasts in a person’s system, according to Kaiser Health News. In particular, the protective effects of the vaccine may wear off faster for people older than the age of 65. Flu activity generally doesn’t peak until January or February.
Survival, PROs Favor Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Advanced NSCLC
December 4th 2023For patients with advanced non–small cell lung cancer (NSCLC), regardless of PD-L1 status, cemiplimab plus chemotherapy had favorable survival benefits and patient-reported outcomes over chemotherapy alone.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Consumers should not eat precut cantaloupe if they do not know the source, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows; the White House and the Department of Education urged schools to take proactive steps to prevent youth drug use; a study published this week found a high prevalence of arrhythmia in patients with long COVID.
Read More